Helping states develop integrated programs for individuals who are dually eligible for Medicare and Medicaid
Helping states develop integrated programs for individuals who are dually eligible for Medicare and Medicaid
On September 8, CMS released the updated Manual for State Payment of Medicare Premiums (formerly called “State Buyin Manual”). The manual updates information and instructions to states on federal policy, operations, and systems concerning the payment of Medicare Parts A and B premiums (or buy-in) for individuals dually eligible for Medicare and Medicaid.
E-alert regarding the following CMS guidance and resources related to the COVID-19 Pandemic:
- Medicare Part A and Part B Enrollment Equitable Relief for the COVID-19 Pandemic
- Updated Guidance for Medicare Advantage and Part D Plans
- New CMS Toolkit on State Actions to Mitigate COVID-19 Prevalence in Nursing Homes
On January 17, 2020, the Centers for Medicare & Medicaid Services (CMS) issued additional guidance and clarification on four topics related to CY2021 requirements for Dual Eligible Special Needs Plans (D-SNPs). The guidance follows on an October 2019 an HPMS memo summarizing the new D-SNP requirements and providing guidance on contract and operational changes needed for CY2021.
Under the Medicare-Medicaid Financial Alignment Initiative, the Centers for Medicare & Medicaid Services (CMS) is measuring consumer experience in multiple ways, including through beneficiary surveys such as the Consumer Assessment of Healthcare Providers and Systems (CAHPS). As part of the MA-PD CAHPS survey, respondents are asked to rate their health plan on a scale from 0 to 10, where 0 is the worst health plan possible and 10 is the best health plan possible.
On November 15, 2019, the Centers for Medicare & Medicaid Services (CMS) issued a final rule implementing a new opioid treatment program (OTP) benefit under Medicare Part B, starting January 1, 2020.